ONMD (ONMD) financial statements
ONMD reported revenue of $1M in fiscal 2025, up 5.6% a year over 3 years.
Net income was -$3M and the operating margin -711.3%, against -669.1% in 2022.
Free cash flow was -$8M.
The diluted share count rose 1021% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from ONMD's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $1M | $1M | $643,000 | $1M |
| Cost of revenue | $2M | $1M | $924,000 | $2M |
| Gross profit | -$360,000 | -$129,000 | -$281,000 | -$503,000 |
| Research and development | $2M | $2M | $1M | $2M |
| Selling, general and admin | $6M | $5M | $8M | $8M |
| Operating income | -$8M | -$7M | -$10M | -$10M |
| Interest expense | $403,307 | $11,000 | $147,000 | $67,000 |
| Pre-tax income | -$30M | -$34M | -$10M | -$3M |
| Income tax | $17,000 | $18,000 | $2,000 | $1,000 |
| Net income | -$30M | -$34M | -$10M | -$3M |
| EPS (diluted) | -$7.66 | -$4.65 | -$0.36 | -$0.06 |
| Diluted shares | 4M | 7M | 28M | 45M |
| Gross margin | -31.2% | -12.6% | -43.7% | -37.0% |
| Operating margin | -669.1% | -671.2% | -1493.8% | -711.3% |
| Net margin | -2641.0% | -3308.5% | -1575.3% | -206.1% |
Balance sheet
Fiscal years, from ONMD's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash and short-term investments | $271,000 | $47,000 | $172,000 | $585,000 |
| Receivables | $19,000 | $152,000 | $213,000 | $495,000 |
| Total current assets | $391,000 | $365,000 | $4M | $2M |
| Property, plant and equipment | $83,000 | $99,000 | $108,000 | $56,000 |
| Total assets | $1M | $464,000 | $4M | $2M |
| Total current liabilities | $26M | $14M | $19M | $5M |
| Total liabilities | $28M | $14M | $20M | $5M |
| Shareholders' equity | -$26M | -$13M | -$16M | -$3M |
| Net debt | -$271,000 | -$47,000 | $9M | $389,000 |
Cash flow
Fiscal years, from ONMD's 10-K filings with the SEC.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | -$5M | -$5M | -$7M | -$8M |
| Capital spending | $58,000 | $44,000 | $51,000 | $13,000 |
| Free cash flow | -$5M | -$5M | -$7M | -$8M |
| Stock-based compensation | $2M | $1M | $628,000 | $2M |
| Net borrowing | — | — | -$200,000 | — |
| Free cash flow margin | -412.9% | -473.6% | -1089.1% | -553.1% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ONMD.
Open ONMD in InvestinglyQuestions
What was ONMD's revenue in 2025?
$1M in fiscal 2025, from its 10-K filing.
How much free cash flow does ONMD generate?
-$8M in fiscal 2025 (operating cash flow minus capital spending).
From ONMD's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.